Abiopharma

Adial Pharmaceuticals Secures U.S.-Based Manufacturing Through Agreements with Cambrex and Thermo Fisher Scientific for Drug Substance and Drug Product Supply

GeneDx Announces Publication of SeqFirst Study Demonstrating Need for First Tier Rapid Genomic Testing for Non-Critical Care Pediatric Inpatients in The Journal of Pediatrics

Glucotrack and OneTwo Analytics Present Positive Final Results of First-In-Human Study for Continuous Blood Glucose Monitor at American Diabetes Association’s 85th Scientific Sessions

Ernexa Therapeutics Expands Advisory Board to Form Integrated Scientific and Medical Advisory Board as it Prepares for Clinical Development

Intelligent Bio Solutions and Spjotgard Drive Rapid Adoption of Fingerprint Drug Testing Across Scandinavia

Biodexa Announces Activation of First Clinical Study Site for Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP)

Hoth Therapeutics Notification (HOTH)

New Form 8-K - Ovid Therapeutics Inc. Filed: 2025-06-25 AccNo: 0001628280-25-032959 Size: 209 KB Item 8.01: Other Events

New Form 8-K - Grace Therapeutics, Inc. Filed: 2025-06-25 AccNo: 0001140361-25-023557 Size: 190 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 6-K - Evaxion A/S Filed: 2025-06-25 AccNo: 0001171843-25-004098 Size: 16 KB

Stryker receives FDA clearance for Incompass Total Ankle System

InMed Pharmaceuticals Announces $5 Million Private Placement Priced At-the-Market Under Nasdaq Rules

New Form SCHEDULE 13D/A - XYLO TECHNOLOGIES LTD Filed: 2025-06-25 AccNo: 0001213900-25-057477 Size: 11 KB

New Form 8-K - Q32 Bio Inc. Filed: 2025-06-25 AccNo: 0001193125-25-146179 Size: 158 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

SeaStar Medical - SeaStar Medical Reports Update on Nasdaq Listing Status